Cargando…

Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption

The role of lymphoid tissue as a potential source of HIV-1 rebound following interruption of antiretroviral therapy (ART) is uncertain. To address this issue, we compared the latent viruses obtained from CD4(+) T cells in peripheral blood and lymph nodes to viruses emerging during treatment interrup...

Descripción completa

Detalles Bibliográficos
Autores principales: Vibholm, Line K., Lorenzi, Julio C. C., Pai, Joy A., Cohen, Yehuda Z., Oliveira, Thiago Y., Barton, John P., Garcia Noceda, Marco, Lu, Ching-Lan, Ablanedo-Terrazas, Yuria, Del Rio Estrada, Perla M., Reyes-Teran, Gustavo, Tolstrup, Martin, Denton, Paul W., Damsgaard, Tine, Søgaard, Ole S., Nussenzweig, Michel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450127/
https://www.ncbi.nlm.nih.gov/pubmed/30700598
http://dx.doi.org/10.1128/JVI.01920-18
_version_ 1783408979778469888
author Vibholm, Line K.
Lorenzi, Julio C. C.
Pai, Joy A.
Cohen, Yehuda Z.
Oliveira, Thiago Y.
Barton, John P.
Garcia Noceda, Marco
Lu, Ching-Lan
Ablanedo-Terrazas, Yuria
Del Rio Estrada, Perla M.
Reyes-Teran, Gustavo
Tolstrup, Martin
Denton, Paul W.
Damsgaard, Tine
Søgaard, Ole S.
Nussenzweig, Michel C.
author_facet Vibholm, Line K.
Lorenzi, Julio C. C.
Pai, Joy A.
Cohen, Yehuda Z.
Oliveira, Thiago Y.
Barton, John P.
Garcia Noceda, Marco
Lu, Ching-Lan
Ablanedo-Terrazas, Yuria
Del Rio Estrada, Perla M.
Reyes-Teran, Gustavo
Tolstrup, Martin
Denton, Paul W.
Damsgaard, Tine
Søgaard, Ole S.
Nussenzweig, Michel C.
author_sort Vibholm, Line K.
collection PubMed
description The role of lymphoid tissue as a potential source of HIV-1 rebound following interruption of antiretroviral therapy (ART) is uncertain. To address this issue, we compared the latent viruses obtained from CD4(+) T cells in peripheral blood and lymph nodes to viruses emerging during treatment interruption. Latent viruses were characterized by sequencing near-full-length (NFL) proviral DNA and env from viral outgrowth assays (VOAs). Five HIV-1-infected individuals on ART were studied, four of whom participated in a clinical trial of a TLR9 agonist that included an analytical treatment interruption. We found that 98% of intact or replication-competent clonal sequences overlapped between blood and lymph node. In contrast, there was no overlap between 205 latent reservoir and 125 rebound sequences in the four individuals who underwent treatment interruption. However, rebound viruses could be accounted for by recombination. The data suggest that CD4(+) T cells carrying latent viruses circulate between blood and lymphoid tissues in individuals on ART and support the idea that recombination may play a role in the emergence of rebound viremia. IMPORTANCE HIV-1 persists as a latent infection in CD4(+) T cells that can be found in lymphoid tissues in infected individuals during ART. However, the importance of this tissue reservoir and its contribution to viral rebound upon ART interruption are not clear. In this study, we sought to compare latent HIV-1 from blood and lymph node CD4(+) T cells from five HIV-1-infected individuals. Further, we analyzed the contribution of lymph node viruses to viral rebound. We observed that the frequencies of intact proviruses were the same in blood and lymph node. Moreover, expanded clones of T cells bearing identical proviruses were found in blood and lymph node. These latent reservoir sequences did not appear to be the direct origin of rebound virus. Instead, latent proviruses were found to contribute to the rebound compartment by recombination.
format Online
Article
Text
id pubmed-6450127
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-64501272019-04-19 Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption Vibholm, Line K. Lorenzi, Julio C. C. Pai, Joy A. Cohen, Yehuda Z. Oliveira, Thiago Y. Barton, John P. Garcia Noceda, Marco Lu, Ching-Lan Ablanedo-Terrazas, Yuria Del Rio Estrada, Perla M. Reyes-Teran, Gustavo Tolstrup, Martin Denton, Paul W. Damsgaard, Tine Søgaard, Ole S. Nussenzweig, Michel C. J Virol Genetic Diversity and Evolution The role of lymphoid tissue as a potential source of HIV-1 rebound following interruption of antiretroviral therapy (ART) is uncertain. To address this issue, we compared the latent viruses obtained from CD4(+) T cells in peripheral blood and lymph nodes to viruses emerging during treatment interruption. Latent viruses were characterized by sequencing near-full-length (NFL) proviral DNA and env from viral outgrowth assays (VOAs). Five HIV-1-infected individuals on ART were studied, four of whom participated in a clinical trial of a TLR9 agonist that included an analytical treatment interruption. We found that 98% of intact or replication-competent clonal sequences overlapped between blood and lymph node. In contrast, there was no overlap between 205 latent reservoir and 125 rebound sequences in the four individuals who underwent treatment interruption. However, rebound viruses could be accounted for by recombination. The data suggest that CD4(+) T cells carrying latent viruses circulate between blood and lymphoid tissues in individuals on ART and support the idea that recombination may play a role in the emergence of rebound viremia. IMPORTANCE HIV-1 persists as a latent infection in CD4(+) T cells that can be found in lymphoid tissues in infected individuals during ART. However, the importance of this tissue reservoir and its contribution to viral rebound upon ART interruption are not clear. In this study, we sought to compare latent HIV-1 from blood and lymph node CD4(+) T cells from five HIV-1-infected individuals. Further, we analyzed the contribution of lymph node viruses to viral rebound. We observed that the frequencies of intact proviruses were the same in blood and lymph node. Moreover, expanded clones of T cells bearing identical proviruses were found in blood and lymph node. These latent reservoir sequences did not appear to be the direct origin of rebound virus. Instead, latent proviruses were found to contribute to the rebound compartment by recombination. American Society for Microbiology 2019-04-03 /pmc/articles/PMC6450127/ /pubmed/30700598 http://dx.doi.org/10.1128/JVI.01920-18 Text en Copyright © 2019 Vibholm et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Genetic Diversity and Evolution
Vibholm, Line K.
Lorenzi, Julio C. C.
Pai, Joy A.
Cohen, Yehuda Z.
Oliveira, Thiago Y.
Barton, John P.
Garcia Noceda, Marco
Lu, Ching-Lan
Ablanedo-Terrazas, Yuria
Del Rio Estrada, Perla M.
Reyes-Teran, Gustavo
Tolstrup, Martin
Denton, Paul W.
Damsgaard, Tine
Søgaard, Ole S.
Nussenzweig, Michel C.
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
title Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
title_full Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
title_fullStr Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
title_full_unstemmed Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
title_short Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
title_sort characterization of intact proviruses in blood and lymph node from hiv-infected individuals undergoing analytical treatment interruption
topic Genetic Diversity and Evolution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450127/
https://www.ncbi.nlm.nih.gov/pubmed/30700598
http://dx.doi.org/10.1128/JVI.01920-18
work_keys_str_mv AT vibholmlinek characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT lorenzijuliocc characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT paijoya characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT cohenyehudaz characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT oliveirathiagoy characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT bartonjohnp characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT garcianocedamarco characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT luchinglan characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT ablanedoterrazasyuria characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT delrioestradaperlam characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT reyesterangustavo characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT tolstrupmartin characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT dentonpaulw characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT damsgaardtine characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT søgaardoles characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption
AT nussenzweigmichelc characterizationofintactprovirusesinbloodandlymphnodefromhivinfectedindividualsundergoinganalyticaltreatmentinterruption